The Readout Loud

A podcast by STAT - Thursdays

Categories:

306 Episodes

  1. 264: Messy PBM conflicts, debatable vaccines, & the future of flu season

    Published: 6/22/2023
  2. 263: Biogen's messy board, Laronde's data problem, & the downside of a boom

    Published: 6/15/2023
  3. 262: Merck v. USA, the best of ASCO, and Leqembi at the FDA

    Published: 6/8/2023
  4. 261: Fake medical devices, real cancer drugs, & curious Ozempic effects

    Published: 6/1/2023
  5. 260: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA

    Published: 5/25/2023
  6. 259: The FTC v. Amgen, Sarepta's future, & Galapagos' turnaround

    Published: 5/18/2023
  7. 258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry

    Published: 5/11/2023
  8. 257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business

    Published: 5/4/2023
  9. 256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval

    Published: 4/27/2023
  10. 255: Sarepta's pivotal moment, biotech's big week, & the future of Covid boosters

    Published: 4/20/2023
  11. 254: The legal battle over abortion, an FDA 'bully pulpit' and Moderna's future

    Published: 4/13/2023
  12. 253: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

    Published: 4/6/2023
  13. 252: Biotech's monkey shortage, the broken generics market, & conference cancel culture

    Published: 3/30/2023
  14. 251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster

    Published: 3/23/2023
  15. 250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

    Published: 3/16/2023
  16. 249: Robert Califf on how drugs get approved, plus the nascent revolution in obesity

    Published: 3/9/2023
  17. 248: The next CRISPR fight, cheaper insulin, & an FDA shuffle

    Published: 3/2/2023
  18. 247: Vertex vs. insurers, Moderna's future, & biotech's long winter

    Published: 2/23/2023
  19. 246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid

    Published: 2/16/2023
  20. 245: The return of bird flu and the effects of pandemic fatigue

    Published: 2/9/2023

3 / 16

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.